NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,185,483 | -13.0% | 992,470 | -10.8% | 0.04% | -10.6% |
| Q2 2023 | $8,262,702 | +14.3% | 1,112,073 | +6.6% | 0.05% | -4.1% |
| Q1 2023 | $7,229,910 | +44.0% | 1,043,277 | +113.6% | 0.05% | +16.7% |
| Q4 2022 | $5,022,027 | +26.3% | 488,524 | +123.7% | 0.04% | 0.0% |
| Q3 2022 | $3,975,000 | -17.8% | 218,418 | +132.3% | 0.04% | -4.5% |
| Q2 2022 | $4,835,000 | -10.4% | 94,017 | +28.3% | 0.04% | +37.5% |
| Q1 2022 | $5,396,000 | +19.1% | 73,261 | +131.4% | 0.03% | +33.3% |
| Q4 2021 | $4,530,000 | +69.9% | 31,660 | +146.1% | 0.02% | +33.3% |
| Q3 2021 | $2,667,000 | +1.0% | 12,864 | +3.4% | 0.02% | +5.9% |
| Q2 2021 | $2,641,000 | -11.4% | 12,439 | -24.4% | 0.02% | -15.0% |
| Q1 2021 | $2,982,000 | +258.4% | 16,446 | +120.3% | 0.02% | +150.0% |
| Q4 2020 | $832,000 | -63.1% | 7,465 | -64.1% | 0.01% | -70.4% |
| Q3 2020 | $2,252,000 | +28.9% | 20,788 | -0.8% | 0.03% | +8.0% |
| Q2 2020 | $1,747,000 | – | 20,958 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |